Wishing you all the joys of the season! 
North America Parenteral Nutrition Market Forecast to 2030
North America Parenteral Nutrition Market Forecast to 2030 – Regional Analysis – by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals) and End User (Hospitals, Clinics, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rise in Prevalence of Gastrointestinal Diseases Fuels North America Parenteral Nutrition Market
Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and gastric cancer are a few examples of gastrointestinal diseases. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” published in January 2021, functional gastrointestinal disorders have affected over 40% of people across the globe.
Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019. The US (762,890) registered the highest number of cases, with prevalence of 245.3 cases per 100,000 people, respectively. Ulcerative colitis and Crohn’s disease are two of the commonly diagnosed IBDs. Crohn’s disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America and Europe. As per the article titled “Understanding Short Bowel Syndrome: Current Status and Future Perspectives,” published in 2020, the prevalence of short bowel syndrome (SBS) has increased by more than twofold in the last 40 years. The prevalence was ~30 cases per million in the US and approximately 1.4 cases per million in Europe.
Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They might also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Hence, medical nutrition is recommended for gastrointestinal disease patients as they are unable to ingest food. Further, the parenteral routes are preferred to provide them with essential nutrients. Some people might not show compatibility with tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs as they are diagnosed with diseases such as cancer and chronic diseases, which affect the gastrointestinal tract. This type of nutrition is highly preferred as a therapy option for most patients suffering from severe SBS. Therefore, the growing prevalence of gastrointestinal diseases drives the parenteral nutrition market.
North America Parenteral Nutrition Market Overview
Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. According to an article titled “Trends in Parenteral Nutrition,” published in January 2019; on average, ~34,000 patients receive parenteral nutrition (PN) annually in the US. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.
The US government is working on making people aware of enteral and parenteral nutrition through initiatives. For instance, the Feeding Tube Awareness Foundation creates awareness about the adoption of feeding tubes as a lifesaving medical intervention and helps parents of tube-fed children. The foundation celebrated the annual Feeding Tube Awareness Week from February 4, 2019, to February 8, 2019. In addition, a significant rise in US Food and Drug Administration (FDA) approvals of products by market players is likely to play a key role in the market growth during the forecast period. For instance, in March 2022, Fresenius Kabi received FDA approval for its SMOFlipid lipid injectable emulsion. The emulsion is the first and only four-oil lipid emulsion for patients of all ages requiring parenteral nutrition.
Therefore, the growing incidence of chronic diseases requiring medical nutrition, government efforts to raise awareness about the importance of parenteral nutrition, and strategic initiatives by key players support the growth of the parenteral nutrition market in the United States.
North America Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
North America Parenteral Nutrition Market Segmentation
The North America parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the North America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins & minerals. The single dose amino acid solution segment held the largest market share in 2022.
By end user, the North America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.
Based on country, the North America parenteral nutrition market is segmented into the US, Canada, and Mexico. The US dominated the North America parenteral nutrition market share in 2022.
ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the North America parenteral nutrition market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the North America parenteral nutrition market was valued at US$ 3,012.06 million in 2022 and is expected to reach US$ 4,805.31 million by 2030, registering a CAGR of 6.0% from 2022 to 2030. Innovation in formulations of nutrition products and surge in cases of malnutrition and premature births are among the critical factors attributed to the North America parenteral nutrition market expansion.
There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.
Significant developments in Innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care. Thus, innovation in the formulations of nutrition products is anticipated to create opportunities for the market growth during the forecast period. Thus, the innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.
On the contrary, mechanical, gastrointestinal, and metabolic complications associated with parenteral feeding systems hampers the growth of North America parenteral nutrition market.
Based on nutrient type, the North America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held 33.2% market share in 2022, amassing US$ 1,000.02 million. It is projected to garner US$ 1,580.03 million by 2030 to register 5.9% CAGR during 2022-2030.
In terms of end user, the North America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held 59.7% share of North America parenteral nutrition market in 2022, amassing US$ 1,797.37 million. It is projected to garner US$ 2,790.69 million by 2030 to expand at 5.7% CAGR during 2022-2030.
Based on country, the North America parenteral nutrition market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.4% share of North America parenteral nutrition market in 2022. It was assessed at US$ 2,512.06 million in 2022 and is likely to hit US$ 4,048.26 million by 2030, exhibiting a CAGR of 6.1% during 2022-2030.
Key players operating in the North America parenteral nutrition market are ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG, among others.
In November 2020, Otsuka Pharmaceuticals Co Ltd launched “ENEFLUID Injection,” the amino acid, glucose, electrolyte, fat, and water-soluble vitamin injection. This product is the first peripheral parenteral nutrition solution in Japan that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amino acids in a dual-chamber bag.
In December 2022, At the 2022 Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP), Baxter International Inc announced the introduction of the ExactaMix Pro Automated Compounder in the US. The product debuted in the beginning of 2023. The recently released product makes use of cutting-edge compounding technology to enhance patient safety, process effectiveness, and formulation accuracy.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America parenteral nutrition market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Parenteral Nutrition Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 New Product Developments by Companies
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market – North America Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
6. North America Parenteral Nutrition Market Analysis – by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Parenteral Nutrition Market Analysis – by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Parenteral Nutrition Market – Country Analysis
8.1 North America: Parenteral Nutrition Market
8.1.1 North America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
8.1.1.1 United States: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 United States: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 United States: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 United States: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Canada: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 Canada: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 Mexico: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 Mexico: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Vifor Pharma Management AG
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The the Reporting Teams
11.2 Glossary of Terms
Table 1. Parenteral Nutrition Market Segmentation
Table 2. United States: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 3. United States: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 4. Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 5. Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 6. Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 7. Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 8. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 9. Glossary of Terms, Parenteral Nutrition Market
Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Parenteral Nutrition Market Share (%) – by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) – by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 16. North America: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. United States: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 19. Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
The List of Companies – North America Parenteral Nutrition Market
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Vifor Pharma Management AG
You must be logged in to post a review.
Reviews
There are no reviews yet.